Directory → Immunotropona funds → Immunomodulators → Ribomunil

This page is translated automatically with a help of Google Translate

Ribomunil

Roman name

Ribomunyl

Pharmacokinetics

The drug is a combination of its components, is a kinetic observation is not possible.

Farmakodinamika

It is a matter of education-specific antibodies to the Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae (through ribosom containing antigens identical antigens these bacteria), the effect of the vaccine. Activates phagocytosis (macrophagic, polinoclearnyi), and increases non-factors resistance (through membrane protheoglicanov) : stimulates the air and B-limfozitov, whey products and secretornah immunoglobulins, interleikina-1 alpha and gamma-interferonov.

Clinical pharmacology

The effectiveness is determined by a combination of the properties of the oral vaccine and immunocorrector domain. Formulates long memory immune to the agent does not require the source of immune status and facilitates course of the disease and speeds up the recovery.

Indications

Prevention and treatment of recidivating respiratory infections (chronic bronchitis, tracheitis, pneumonia) and Lor-organov (otitis, sinusit, tonsillitis, rhinitis, pharyngitis, laringit).

Pregnancy and lactation

The preparation may be nominated in pregnancy and lactation (breast-feeding).

Contraindications

Hypersensitivity to the drug.

Side-Effects

Gipersalivacia (early treatment).

Specific guidance

Ribomunil should be cautious appoint patients with autoimmune diseases, uzelkovm periarteriitom, HIV-infected patients.

Patient interaction

Not noted.

Overdosing

Currently, the cases of drug overdose Ribomunil were reported.

Precautions

Be wary appoint autoimmune diseases uzelkovom periarteriite.

Storage conditions

In a cool dry place.

Shelf life

3 years

The registration

011369/01-1999

Of drugs

Immunostimulating (enhanced immunity, the immune system) means increasing specificity and Baby immunity.

Indications for use

Retidivirute (recurring) respiratory tract infections, bronchitis, Lor-infection (prevention).

Dosing and Administration

Inside 3 pills on the morning of prandial 4 days a week for three weeks in the first month of treatment, in the next five months, and 4 days per month.

Form of

Pills. One tablet contains ribosom 0.00025 g and protheoglicanov membrane of the city 0.000375